Company Biomerica, Inc.

Equities

BMRA

US09061H3075

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 02:15:04 2024-04-19 pm EDT 5-day change 1st Jan Change
0.749 USD -1.45% Intraday chart for Biomerica, Inc. -10.02% -40.40%

Business Summary

Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company's InFoods IBS product uses a simple blood sample and is designed to identify patient-specific foods that, when removed from the diet, may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The Company’s two subsidiaries, Biomerica de Mexico, which is used for assembly/manufacturing and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets.

Sales per Business

USD in Million2022Weight2023Weight Delta
Clinical Lab
62.0 %
3 16.2 % 3 62.0 % +8.03%
Over-the-counter
21.9 %
1 5.8 % 1 21.9 % +7.35%
Contract Manufacturing
11.4 %
0 2.4 % 1 11.4 % +32.90%
Physicians' Office
4.7 %
14 75.6 % 0 4.7 % -98.25%

Sales per region

USD in Million2022Weight2023Weight Delta
Asia
37.9 %
13 70.9 % 2 37.9 % -84.89%
Europe
33.7 %
4 23.0 % 2 33.7 % -58.56%
North America
27.5 %
1 5.3 % 1 27.5 % +47.44%
Middle East
0.7 %
0 0.4 % 0 0.7 % -44.29%
South America
0.2 %
0 0.5 % 0 0.2 % -87.78%

Managers

Managers TitleAgeSince
Chief Executive Officer 58 85-12-31
Director of Finance/CFO 43 23-02-28
Corporate Officer/Principal - 22-08-29

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 58 85-12-31
Director/Board Member 65 99-09-30
Director/Board Member 70 07-03-31
Director/Board Member 46 22-12-06
Chairman 54 23-08-24
Director/Board Member 58 20-09-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,821,646 15,592,969 ( 92.70 %) 0 92.70 %

Shareholders

NameEquities%Valuation
Granahan Investment Management, LLC
6.436 %
1,082,672 6.436 % 900 783 $
1,020,560 6.067 % 849 106 $
Wasatch Advisors, Inc.
5.667 %
953,264 5.667 % 793 116 $
Vanguard Group, Inc. (Subfiler)
3.623 %
609,365 3.623 % 506 992 $
Russell Investments Group Ltd.
1.198 %
201,563 1.198 % 167 700 $
Potomac Capital Management, Inc.
0.9969 %
167,700 0.9969 % 139 526 $
BlackRock Institutional Trust Co. NA
0.8900 %
149,707 0.8900 % 124 556 $
Geode Capital Management LLC
0.7180 %
120,784 0.7180 % 100 492 $
93,327 0.5548 % 77 648 $
Susquehanna Securities LLC
0.4513 %
75,916 0.4513 % 63 162 $
NameEquities%Valuation
Palm Management Us LLC
100.00 %
571,429 100.00 % 475 429 $

Company contact information

Biomerica, Inc.

17571 Von Karman Avenue

92614, Irvine

+

http://www.biomerica.com
address Biomerica, Inc.(BMRA)
  1. Stock Market
  2. Equities
  3. BMRA Stock
  4. Company Biomerica, Inc.